Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer
Conclusions: DPP4i seems to improve survival in PRC patients; however, not in PC or BC patients. While the exact mechanism involved remains to be elucidated, a prospective clinical trial would help to confirm these findings.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Fortamet | Medicare | Metformin | Pancreas | Pancreatic Cancer | Prostate Cancer | Prostatectomy | Radiation Therapy | Study